- Opened new bridge round, raised $1M
- Grew team to 9 employees, plus one intern
- Awarded NIH Phase 2B grant ($3M) for IND-enabling toxicology studies
- Subcontract for DARPA FSHARP $46M consortium award to UMB ($3.2M to KaloCyte)
- Comcast RISE Award recipient
- Maryland Tech Council ICON Awards finalist – Emerging Life Science Company of the Year
- Qualified Maryland Biotech Company (QMBC) for State Biotech Investment Initiative Tax Credit (BIITC)
- Finalist in the 8th Annual Biohealth Capital Region’s Crab Trap Pitch Event
